Primary Record
golidocitinib
- In stock
- 6,492 g
- Purity
- 99.2 %
- CAS
- 2091134-68-6
Compound Identifiers & Properties
- CAS
- 2091134-68-6
- PubChem CID
- 126715380
- SMILES
- C[C@H](C(=O)NC1=CC=CC2=C1NC=C2C3=NC(=NC=C3)NC4=CN(N=C4OC)C)N5CCN(CC5)C
- Canonical SMILES
- COc1nn(C)cc1Nc1nccc(-c2c[nH]c3c(NC(=O)[C@@H](C)N4CCN(C)CC4)cccc23)n1
Names & Synonyms
- golidocitinib
- AZD-4205
- JAK1-IN-3
- 2091134-68-6
- AZD4205
- UNII-3BY9Z3M34G
- 3BY9Z3M34G
- AZD4205 free base
- GOLIDOCITINIB [INN]
- Golidocitinib [WHO-DD]
- RefChem:144119
- Golidocitinib(AZD4205)
- Golidocitinib (USAN/INN)
- GOLIDOCITINIB [USAN]
- JAK1 Inhibitor AZD4205
- GaoRuizhe (Chinese trade name)
- orb1309956
- AZD 4205
- CHEMBL4577523
- SCHEMBL18662606
- SCHEMBL29389079
- GTPL10744
- BDBM264212
- C25H31N9O2
- GLXC-22410
- EX-A2671
- AZD 4205?
- example 32 [US9714236B2]
- MFCD31657353
- NSC801813
- AKOS040732508
- AT40403
- NSC-801813
- compound 21 [PMID: 32297743]
- AC-36748
- BA177711
- MS-29106
- HY-107361
- CS-0028212
- D12502
- (2R)-N-[3-[2-[(3-methoxy-1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1H-indol-7-yl]-2-(4-methylpiperazin-1-yl)propanamide
- US9714236, 32
- A1017409
- (R)-N-(3-(2-((3-Methoxy-1-methyl-1h-pyrazol-4-yl)amino)pyrimidin-4-yl)-1h-indol-7-yl)-2-(4-methylpiperazin-1-yl)propanamide
- (R)-N-(3-{2-[(3-Methoxy-1-methyl-1H-pyrazol-4-yl)amino]pyrimidin-4-yl}-1H-indol-7-yl)-2-(4-methylpiperazin-1-yl)propanamide
- 1-Piperazineacetamide, N-(3-(2-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-4-pyrimidinyl)-1H-indol-7-yl)-alpha,4-dimethyl-, (alphaR)-
- (.ALPHA.R)-N-(3-(2-((3-METHOXY-1-METHYL-1H-PYRAZOL-4-YL)AMINO)-4-PYRIMIDINYL)-1H-INDOL-7-YL)-.ALPHA.,4-DIMETHYL-1-PIPERAZINEACETAMIDE
- (2R)-N-(3-(2-((3-methoxy-1-methylpyrazol-4-yl)amino)pyrimidin-4-yl)-1H-indol-7-yl)-2-(4-methylpiperazin-1-yl)propanamide
- (2R)-N-(3-{2-[(3- methoxy-1-methyl- 1H-pyrazol-4-yl)amino] pyrimidin-4- yl}-1H-indol-7-yl)-2-(4- methylpiperazin-1- yl)propanamide
- (2R)-N-(3-{2-[(3-methoxy-1-methyl-1H-pyrazol-4-yl)amino]pyrimidin-4-yl}-1H-indol-7-yl)-2-(4-methylpiperazin-1-yl)propanamide
- (2R)-N-[3-[2-[(3-methoxy-1-methyl-pyrazol-4-yl)amino]pyrimidin-4-yl]-1H-indol-7-yl]-2-(4-methylpiperazin-1-yl)propanamide
- (2R)-N-[3-[2-[(3-Methoxy-1-methyl-pyrazol-4-yl)amino]pyrimidin-4-yl]-1H-indol-7-yl]-2-(4-methylpiperazin-1-yl)propenamide
- (ALPHAR)-N-(3-(2-((3-METHOXY-1-METHYL-1H-PYRAZOL-4-YL)AMINO)-4-PYRIMIDINYL)-1H-INDOL-7-YL)-ALPHA,4-DIMETHYL-1-PIPERAZINEACETAMIDE
- (alphaR)-N-[3-[2-[(3-Methoxy-1-methyl-1H-pyrazol-4-yl)amino]-4-pyrimidinyl]-1H-indol-7-yl]-alpha,4-dimethyl-1-piperazineacetamide
- (R)-N-(3-(2-(3-Methoxy-1-methyl-1H-pyrazol-4-ylamino)pyrimidin-4-yl)-1H-indol-7-yl)-2-(4-methylpiperazin-1-yl)propanamide
- 1-Piperazineacetamide, N-[3-[2-[(3-methoxy-1-methyl-1H-pyrazol-4-yl)amino]-4-pyrimidinyl]-1H-indol-7-yl]-alpha,4-dimethyl-, (alphaR)-